Global: Early-stage healthcare funding focused on France and Africa
Healthcare companies came out of the gates running in the first week of the year with early-stage healthcare funding focused on Europe and Africa. French medtech company CorWave has raised €35m (US$42.7m) in Series C funding. Existing shareholders Bpifrance, Novo Holdings, Seventure, Sofinnova Partners and Ysios Capital significantly increased their stake in the company and…
You must be a HMI Subscriber to view this content.
Adrian Murdoch has more than 25 years’ experience as an international journalist. He started his career at World Link, the magazine of the World Economic Forum. He covered debt capital markets for Reuters in Singapore throughout the Asian Financial Crisis, and then the European Central Bank in Frankfurt. As a freelancer he has worked for Forbes, The Wall Street Journal, Euromoney, the Scotsman and the BBC. The author of a number of books on the classical world, Adrian has written and pr
TORONTO, Jan. 05, 2021 Compass Gold Corporation (TSX-V: CVB) (Compass or the Company) announced today that the Board of Directors has approved the issuance
Announcing the GovTech 100 Companies for 2021
SACRAMENTO, Calif., Jan. 05, 2021
Government Technology magazine released its annual GovTech 100, a compendium of 100 companies focused on making a difference in – and selling to – state and local governments.
Gov tech has earned recognition as its own market segment through the work of a growing number of companies – and the investors that back them – in helping governments perform mission-critical work while serving their communities more effectively. The sixth annual GovTech 100 analysis also highlights the market’s accelerating growth and maturity.
“Although 2020 was an unprecedented year of rapid change and disruption, we saw gov tech companies rapidly adapt their services and solutions to help state and local government agencies navigate the uncertainty,” said e.Republic Chief Innovation Officer Dustin Haisler, who was heavily involved in the list’s creation.
PDS Biotech Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
PDS Biotech Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
FLORHAM PARK, N.J., Jan. 05, 2021 PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced that Chief Executive Officer Dr. Frank Bedu-Addo will be presenting at H.C. Wainwright’s BioConnect virtual conference. PDS Biotech’s presentation will be available on-demand beginning January 11, 2021 at 6:00 AM ET and can be accessed online here.
A replay of the presentation will be available online in the investor relations section of the Company’s website.